LOCAL NEWS

FDA seizes quantities of tramadol in Wa

The Upper West Region Office of the Food and Drugs Authority (FDA), in collaboration with the Upper West Regional Pharmacy Council, has seized an undisclosed quantity of tramadol from three Over The Counter Medicine Sellers (OTCMSs) in the Wa Municipality.

The OTCMSs were fined administrative charges of GH₵5000.00 each per the dictates of the Public Health Act, Act 851 (2012).

Mr Albert Ankomah, the Upper West Regional Head of the FDA, who made this known noted that they acted upon a tip-off, conducted their investigation and sourced the drugs, which were secretly sold to consumers.

“The Upper West Regional office of the FDA received a consumer complaint, indicating that there are some Over The Counter Medicine Sellers within the Wa Municipality who are secretly selling tramadol to people and so the office quickly investigated this complaint”, he explained.

Section 111 of the Act says, “A person commits an offence if that person sells a drug, herbal medicinal product, cosmetic, medical device or household chemical substance which, has the potential to cause injury to the health of the user”.

Mr Ankomah noted that tramadol was a prescription only medicine and ought to be sold in only pharmacy shops, and that selling the drug in OTCMSs was highly illegal.

He, therefore, urged OTCMSs that were selling tramadol to “their customers” to desist from the act saying, “when the law catches up with them they will be sanctioned”.

He stressed that per the Ghana Health Service regulations, tramadol was not supposed to be prescribed by health facilities that were below the status of a district hospital.

“Also we are informing the general public that tramadol has its own harmful effects when they are abused, so the fight against the abuse of tramadol is still on”, the Regional FDA Boss added.

He noted that the abuse of tramadol had serious adverse effects on the health of the individual, especially his or her brain, and that it would make their future bleak.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button